Management of Aromatase Inhibitor–Induced Musculoskeletal Symptoms-Reference-Cited by-同舟云学术

Management of Aromatase Inhibitor–Induced Musculoskeletal Symptoms

Published:2020-11 Issue:11 Volume:16 Page:733-739
ISSN:2688-1527
Container-title:JCO Oncology Practice
language:en
Short-container-title:JCO Oncology Practice

Author:

Gupta Arjun¹,Henry N. Lynn²,Loprinzi Charles L.³

Affiliation:

1. Department of Medical Oncology, Johns Hopkins University, Baltimore, MD

2. Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI

3. Department of Oncology, Mayo Clinic, Rochester, MD

Abstract

Aromatase inhibitor–induced musculoskeletal symptoms (AIMSS) were first recognized as a distinct entity in 2001, 5 years after the approval of the first aromatase inhibitor, anastrozole. Musculoskeletal symptoms can severely affect patients’ quality of life and also lead to premature discontinuation of aromatase inhibitor therapy. Several interventions for managing AIMSS have been investigated in the last decade, with some demonstrating promise. This article provides an evidence-based summary to guide practicing oncologists in regard to the epidemiology, prevention, and treatment of AIMSS.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Oncology(nursing),Health Policy,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/OP.20.00113

Reference46 articles.

1. Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials

2. Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

3. Nodal Metastasis Is Highly Consistent in Squamous Cell Carcinoma of the Vulva

4. Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors

5. Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast Cancer

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Event Profiles of the Third-Generation Aromatase Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS;Biomedicines;2024-08-01

2. Evaluation and Management of Shoulder Dysfunction in Cancer Survivors;Current Physical Medicine and Rehabilitation Reports;2024-06-13

3. Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer;Breast Cancer Research and Treatment;2024-01-10

4. Muscle and Tendon;Haschek and Rousseaux' s Handbook of Toxicologic Pathology;2024

5. Advances in Cancer Pain Management;Handbook of Oncobiology: From Basic to Clinical Sciences;2024